Fanazavana fanampiny ― Malagasy

Urticaria matetika miseho amin'ny fivontosana mangidihidy mafy. Indraindray izy io dia miaraka amin'ny fivontosan'ny sela ao ambaniny. Ny fitsaboana dia ny fisorohana ny trigger, raha fantatra. Ny fanafody voalohany dia misy antihistamines vaovao kokoa, izay azo ampifanarahana amin'ny fatra avo kokoa raha ilaina. Ny fanafody hafa toy ny antihistamines taloha, ny H2 blockers, ny leukotriene receptor antagonists, ny antihistamines matanjaka kokoa, ary ny corticosteroids fohy dia azo ampiana ho fanohanana fanampiny. Amin'ny tranga izay mbola mitohy ny urticaria na dia eo aza ireo fepetra ireo, ny marary dia azo alefa any amin'ny manam-pahaizana manokana momba ny fitsaboana fanampiny toy ny omalizumab na cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Ity famerenana ity dia mamaritra ny torolàlana farany momba ny fitsaboana ny urticaria ary manolotra fahatakarana vaovao momba ny antony mahatonga azy.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids